Gemma Biotherapeutics ("GEMMABio"), a clinical‑stage, global, genetic medicines company, today announced the presentation of preclinical data supporting candidate declaration for GB703, a novel, ...
Hundreds more children with muscle-wasting condition spinal muscular atrophy (SMA) are to be offered potentially “life-changing” therapy on the NHS which could help them live ...
MEDICINES for babies with spinal muscular atrophy will be funded by the NHS for all patients for the first time. Little Mix ...
Medicines watchdog approves two treatments for patients with spinal muscular atrophy ...
The Independent on MSN
Five early signs of SMA every parent should look out for
What is SMA? Key signs to look out for in babies as Jesy Nelson highlights life-changing condition - Pop star Jesy Nelson has ...
Clinical bosses approve the treatment for routine and widespread NHS use in England.
SMA is a rare, inherited condition that causes progressive muscle weakness, affecting movement, breathing and swallowing. Without treatment, the condition can lead to severe disability and, in its ...
The family of a three-year-old girl with a rare muscle disease are facing a bill of £7,000 for adaptations to their home.
Spinal muscular atrophy is a rare, genetic condition that causes progressive muscle weakness and loss of movement, and can ...
Spinal muscular atrophy (SMA) is a genetic, progressive neuromuscular disorder. SMA affects muscle-controlling nerve cells, called motor neurons, in the spinal cord. The condition leads to muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results